HSBC Holdings plc vs Nuwellis Inc — how do they compare? HSBC Holdings plc trades at $104 (market cap $353.82B), while Nuwellis Inc trades at $1.41 (market cap $542.80K). The key difference: HSBC Holdings plc is far larger — about 651842.3× Nuwellis Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| HSBC | NUWE | |
|---|---|---|
Market Cap | $353.82B | $542.80K |
Sector | Technology | Technology |
52-Week High | $107.86 | $220.50 |
52-Week Low | $63.84 | $1.42 |
Dividend Yield | 3.63% | — |
Enterprise Value | — | -$1.27M |
Signals from Pluang's Aura AI — not financial advice
HSBC trades at $104.12, up 0.77% today, with a bullish technical signal from moving averages and support near $103. The bank reported strong Q2 2026 results with a 7% revenue increase and a $1 billion buyback, while net income margin improved to 34.54% in 2026. Analyst sentiment is mixed, with 38.1% buy ratings, but recent news includes a Citi downgrade citing a 40% stock run-up.
The outlook remains positive due to earnings momentum and shareholder returns, but risks include China regulatory changes and valuation concerns after the recent rally. Further upside depends on sustained revenue growth and effective capital allocation.
NUWE trades at $1.41, down 0.7% today, with a bearish technical signal despite oversold RSI readings. The company reported a net loss of $17.52 million on $8.27 million revenue in 2025, with negative cash flow from operations. Recent news highlights expansion in pediatric care and a $3.4 million direct offering in July 2026, alongside a reverse stock split executed in June 2026.
Outlook remains challenged by persistent losses and high cash burn, though revenue growth and product development offer potential. Risks include reliance on financing and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid fundamental weaknesses.
Trailing returns across standard periods
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →